Implantable hearing solutions provider Cochlear has launched a new perimodiolar electrode for cochlear implants.

The new Cochlear Nucleus Profile Implant with Slim Modiolar Electrode (CI532) is designed to preserve hearing structuresand increase hearing performance.

Its thin design will help to protect and preserve the delicate structures of the inner ear, while delivering better hearing performance.

According to the company, the independent research demonstrated that electrode contacts positioned closer to the hearing nerve improved hearing performance in patients with severe to profound hearing loss

Cochlear North America president Tony Manna said: "Our new Slim Modiolar Electrode is the latest perimodiolar array innovation in our portfolio of electrodes, and it really does make a difference for our customers and the surgeon.

"Feedback from leading surgeons around the world provided us with valuable insights as we developed this electrode.”

Featuring an advanced insertion mechanism, the new electrode enables surgeons to adjust their electrode insertion approach for the individual patient's needs.

The company has designed the new electrode to compatible with round window, extended round window and cochleostomy insertion approaches. It can also be reloaded if required.

The firm produces produces cochlear implants, bone conduction and acoustic implants to treat a range of moderate to profound types of hearing loss

Earlier this month, the firm secured approval from the US Food and Drug Administration (FDA) for its new Kanso hearing loss solution. It was developed to treat severe to profound hearing loss.

Image: The new Nucleus Profile implant with slim modiolar electrode si designed to preserve hearing structures. Photo: courtesy of PRNewsFoto / Cochlear.